{"id":610,"date":"2024-02-29T17:22:00","date_gmt":"2024-02-29T16:22:00","guid":{"rendered":"https:\/\/diabete.movigroup.com\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/"},"modified":"2025-03-18T12:37:53","modified_gmt":"2025-03-18T11:37:53","slug":"control-iq-dexcom-g7-lultima-innovazione-per-il-diabete","status":"publish","type":"post","link":"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/","title":{"rendered":"Control-IQ &amp; Dexcom G7: The Latest Innovation For Diabetes"},"content":{"rendered":"\n<p><style class=\"WebKit-mso-list-quirks-style\"><br>&lt;!--<br>\/* Style Definitions *\/<br> p.MsoNormal, li.MsoNormal, div.MsoNormal<br>\t{mso-style-unhide:no;<br>\tmso-style-qformat:yes;<br>\tmso-style-parent:\"\";<br>\tmargin-top:0cm;<br>\tmargin-right:0cm;<br>\tmargin-bottom:8.0pt;<br>\tmargin-left:0cm;<br>\tline-height:115%;<br>\tmso-pagination:widow-orphan;<br>\tfont-size:12.0pt;<br>\tfont-family:\"Aptos\",sans-serif;<br>\tmso-ascii-font-family:Aptos;<br>\tmso-ascii-theme-font:minor-latin;<br>\tmso-fareast-font-family:Aptos;<br>\tmso-fareast-theme-font:minor-latin;<br>\tmso-hansi-font-family:Aptos;<br>\tmso-hansi-theme-font:minor-latin;<br>\tmso-bidi-font-family:\"Times New Roman\";<br>\tmso-bidi-theme-font:minor-bidi;<br>\tmso-font-kerning:1.0pt;<br>\tmso-ligatures:standardcontextual;<br>\tmso-fareast-language:EN-US;}<br>a:link, span.MsoHyperlink<br>\t{mso-style-priority:99;<br>\tcolor:#467886;<br>\tmso-themecolor:hyperlink;<br>\ttext-decoration:underline;<br>\ttext-underline:single;}<br>a:visited, span.MsoHyperlinkFollowed<br>\t{mso-style-noshow:yes;<br>\tmso-style-priority:99;<br>\tcolor:#96607D;<br>\tmso-themecolor:followedhyperlink;<br>\ttext-decoration:underline;<br>\ttext-underline:single;}<br>p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph<br>\t{mso-style-priority:34;<br>\tmso-style-unhide:no;<br>\tmso-style-qformat:yes;<br>\tmargin-top:0cm;<br>\tmargin-right:0cm;<br>\tmargin-bottom:8.0pt;<br>\tmargin-left:36.0pt;<br>\tmso-add-space:auto;<br>\tline-height:115%;<br>\tmso-pagination:widow-orphan;<br>\tfont-size:12.0pt;<br>\tfont-family:\"Aptos\",sans-serif;<br>\tmso-ascii-font-family:Aptos;<br>\tmso-ascii-theme-font:minor-latin;<br>\tmso-fareast-font-family:Aptos;<br>\tmso-fareast-theme-font:minor-latin;<br>\tmso-hansi-font-family:Aptos;<br>\tmso-hansi-theme-font:minor-latin;<br>\tmso-bidi-font-family:\"Times New Roman\";<br>\tmso-bidi-theme-font:minor-bidi;<br>\tmso-font-kerning:1.0pt;<br>\tmso-ligatures:standardcontextual;<br>\tmso-fareast-language:EN-US;}<br>p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst<br>\t{mso-style-priority:34;<br>\tmso-style-unhide:no;<br>\tmso-style-qformat:yes;<br>\tmso-style-type:export-only;<br>\tmargin-top:0cm;<br>\tmargin-right:0cm;<br>\tmargin-bottom:0cm;<br>\tmargin-left:36.0pt;<br>\tmso-add-space:auto;<br>\tline-height:115%;<br>\tmso-pagination:widow-orphan;<br>\tfont-size:12.0pt;<br>\tfont-family:\"Aptos\",sans-serif;<br>\tmso-ascii-font-family:Aptos;<br>\tmso-ascii-theme-font:minor-latin;<br>\tmso-fareast-font-family:Aptos;<br>\tmso-fareast-theme-font:minor-latin;<br>\tmso-hansi-font-family:Aptos;<br>\tmso-hansi-theme-font:minor-latin;<br>\tmso-bidi-font-family:\"Times New Roman\";<br>\tmso-bidi-theme-font:minor-bidi;<br>\tmso-font-kerning:1.0pt;<br>\tmso-ligatures:standardcontextual;<br>\tmso-fareast-language:EN-US;}<br>p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle<br>\t{mso-style-priority:34;<br>\tmso-style-unhide:no;<br>\tmso-style-qformat:yes;<br>\tmso-style-type:export-only;<br>\tmargin-top:0cm;<br>\tmargin-right:0cm;<br>\tmargin-bottom:0cm;<br>\tmargin-left:36.0pt;<br>\tmso-add-space:auto;<br>\tline-height:115%;<br>\tmso-pagination:widow-orphan;<br>\tfont-size:12.0pt;<br>\tfont-family:\"Aptos\",sans-serif;<br>\tmso-ascii-font-family:Aptos;<br>\tmso-ascii-theme-font:minor-latin;<br>\tmso-fareast-font-family:Aptos;<br>\tmso-fareast-theme-font:minor-latin;<br>\tmso-hansi-font-family:Aptos;<br>\tmso-hansi-theme-font:minor-latin;<br>\tmso-bidi-font-family:\"Times New Roman\";<br>\tmso-bidi-theme-font:minor-bidi;<br>\tmso-font-kerning:1.0pt;<br>\tmso-ligatures:standardcontextual;<br>\tmso-fareast-language:EN-US;}<br>p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast<br>\t{mso-style-priority:34;<br>\tmso-style-unhide:no;<br>\tmso-style-qformat:yes;<br>\tmso-style-type:export-only;<br>\tmargin-top:0cm;<br>\tmargin-right:0cm;<br>\tmargin-bottom:8.0pt;<br>\tmargin-left:36.0pt;<br>\tmso-add-space:auto;<br>\tline-height:115%;<br>\tmso-pagination:widow-orphan;<br>\tfont-size:12.0pt;<br>\tfont-family:\"Aptos\",sans-serif;<br>\tmso-ascii-font-family:Aptos;<br>\tmso-ascii-theme-font:minor-latin;<br>\tmso-fareast-font-family:Aptos;<br>\tmso-fareast-theme-font:minor-latin;<br>\tmso-hansi-font-family:Aptos;<br>\tmso-hansi-theme-font:minor-latin;<br>\tmso-bidi-font-family:\"Times New Roman\";<br>\tmso-bidi-theme-font:minor-bidi;<br>\tmso-font-kerning:1.0pt;<br>\tmso-ligatures:standardcontextual;<br>\tmso-fareast-language:EN-US;}<br>.MsoChpDefault<br>\t{mso-style-type:export-only;<br>\tmso-default-props:yes;<br>\tfont-family:\"Aptos\",sans-serif;<br>\tmso-ascii-font-family:Aptos;<br>\tmso-ascii-theme-font:minor-latin;<br>\tmso-fareast-font-family:Aptos;<br>\tmso-fareast-theme-font:minor-latin;<br>\tmso-hansi-font-family:Aptos;<br>\tmso-hansi-theme-font:minor-latin;<br>\tmso-bidi-font-family:\"Times New Roman\";<br>\tmso-bidi-theme-font:minor-bidi;<br>\tmso-fareast-language:EN-US;}<br>.MsoPapDefault<br>\t{mso-style-type:export-only;<br>\tmargin-bottom:8.0pt;<br>\tline-height:115%;}<br>@page WordSection1<br>\t{size:612.0pt 792.0pt;<br>\tmargin:70.85pt 2.0cm 2.0cm 2.0cm;<br>\tmso-header-margin:36.0pt;<br>\tmso-footer-margin:36.0pt;<br>\tmso-paper-source:0;}<br>div.WordSection1<br>\t{page:WordSection1;}<br> \/* List Definitions *\/<br> @list l0<br>\t{mso-list-id:1813212305;<br>\tmso-list-type:hybrid;<br>\tmso-list-template-ids:-1469802334 68157441 68157443 68157445 68157441 68157443 68157445 68157441 68157443 68157445;}<br>@list l0:level1<br>\t{mso-level-number-format:bullet;<br>\tmso-level-text:\uf0b7;<br>\tmso-level-tab-stop:none;<br>\tmso-level-number-position:left;<br>\ttext-indent:-18.0pt;<br>\tfont-family:Symbol;}<br>@list l0:level2<br>\t{mso-level-number-format:bullet;<br>\tmso-level-text:o;<br>\tmso-level-tab-stop:none;<br>\tmso-level-number-position:left;<br>\ttext-indent:-18.0pt;<br>\tfont-family:\"Courier New\";}<br>@list l0:level3<br>\t{mso-level-number-format:bullet;<br>\tmso-level-text:\uf0a7;<br>\tmso-level-tab-stop:none;<br>\tmso-level-number-position:left;<br>\ttext-indent:-18.0pt;<br>\tfont-family:Wingdings;}<br>@list l0:level4<br>\t{mso-level-number-format:bullet;<br>\tmso-level-text:\uf0b7;<br>\tmso-level-tab-stop:none;<br>\tmso-level-number-position:left;<br>\ttext-indent:-18.0pt;<br>\tfont-family:Symbol;}<br>@list l0:level5<br>\t{mso-level-number-format:bullet;<br>\tmso-level-text:o;<br>\tmso-level-tab-stop:none;<br>\tmso-level-number-position:left;<br>\ttext-indent:-18.0pt;<br>\tfont-family:\"Courier New\";}<br>@list l0:level6<br>\t{mso-level-number-format:bullet;<br>\tmso-level-text:\uf0a7;<br>\tmso-level-tab-stop:none;<br>\tmso-level-number-position:left;<br>\ttext-indent:-18.0pt;<br>\tfont-family:Wingdings;}<br>@list l0:level7<br>\t{mso-level-number-format:bullet;<br>\tmso-level-text:\uf0b7;<br>\tmso-level-tab-stop:none;<br>\tmso-level-number-position:left;<br>\ttext-indent:-18.0pt;<br>\tfont-family:Symbol;}<br>@list l0:level8<br>\t{mso-level-number-format:bullet;<br>\tmso-level-text:o;<br>\tmso-level-tab-stop:none;<br>\tmso-level-number-position:left;<br>\ttext-indent:-18.0pt;<br>\tfont-family:\"Courier New\";}<br>@list l0:level9<br>\t{mso-level-number-format:bullet;<br>\tmso-level-text:\uf0a7;<br>\tmso-level-tab-stop:none;<br>\tmso-level-number-position:left;<br>\ttext-indent:-18.0pt;<br>\tfont-family:Wingdings;}<br><br>--><br><span lang=\"EN-US\" style=\"font-size: 11pt; line-height: 16.866667px;\">The tour organized by\u00a0<b>Movi SpA,<\/b>\u00a0a leading distributor of\u00a0<b>pioneering diagnostic and therapeutic solutions in the field of diabetes,<\/b>\u00a0featured a series of events dedicated to healthcare professionals (with stops in Milan on 02\/26\/24, Bologna on 02\/27\/24, and Rome on 02\/28\/29\/24) for\u00a0<b>the launch of an innovative integrated diabetes management system consisting of the Control-IQ technology pump and the Dexcom G7 sensor.<\/b>The round of presentation events focused mainly on illustrating\u00a0<b>the system\u2019s unique features<\/b>\u00a0and discussing its potential\u00a0<b>positive impact on the daily lives of people undergoing insulin treatment<\/b>. The presence of multiple legs in different cities across the country made it possible to engage a broader audience and at the same time to establish a network at the local level, which is useful for the\u00a0<b>exchange of knowledge, experience, and specific issues that meet the needs of professionals dealing with diabetes.<\/b>The launch of this new technology on the Italian market is an extremely important event, because the\u00a0<b>Tandem t:slim X2 pump with Control-IQ technology was the first AHCL (Advanced Hybrid Closed Loop) system to integrate with Dexcom G7, the \u201cBest in Class\u201d sensor on the market.<\/b>This state-of-the-art medical device,\u00a0<b>launched by the Italian company Movi SpA<\/b>, consists of a pump (<b>Tandem t:slim X2 with Control-IQ technology<\/b>), associated with a continuous blood glucose monitoring sensor (<b>Dexcom G7<\/b>) and a\u00a0<b>predictive control algorithm<\/b>\u00a0that\u00a0<b>automates and customizes insulin delivery based on data from the sensor<\/b>, responding to the specific needs of each person. This approach provides greater flexibility, autonomy, and quality of life for the user.Starting with careful listening and a detailed needs analysis,\u00a0<b>the system was developed to truly meet the real needs of both physician and patient.<\/b>\u00a0Among the main benefits of this new technology are\u00a0<b>greater simplicity in diabetes management, increased reliability of the device, improved quality of life, increased safety in the delivery of glycemic data, and overall optimization of glycemic compensation.<\/b>With this\u00a0<b>innovative device<\/b>, people with diabetes will be able to achieve\u00a0<b>a significant improvement in their quality of life,<\/b>\u00a0as well as\u00a0<b>greater simplicity of therapy management by the clinician<\/b>.<\/span><span lang=\"EN-US\"><\/span><span lang=\"EN-US\" style=\"font-size: 11pt; line-height: 16.866667px;\"><\/span><u><span style=\"font-size: 11pt; line-height: 16.866667px;\">Press review:\u00a0<\/span><\/u><span style=\"font-size: 11pt; line-height: 16.866667px;\"><\/span><span style=\"font-size: 11pt; line-height: 115%; font-family: Symbol;\">\u00b7<span style=\"font-style: normal; font-variant-caps: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;; font-size-adjust: none; font-kerning: auto; font-variant-alternates: normal; font-variant-ligatures: normal; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-position: normal; font-feature-settings: normal; font-optical-sizing: auto; font-variation-settings: normal;\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><\/span><a href=\"https:\/\/www.adnkronos.com\/Archivio\/salute\/diabete-nuova-tecnologia-user-centered-per-gestione-intelligente-malattia_6aE3bZi285kZe9IoqU9PIX?refresh_ce\"><span style=\"font-size: 11pt; line-height: 16.866667px;\">https:\/\/www.adnkronos.com\/Archivio\/salute\/diabete-nuova-tecnologia-user-centered-per-gestione-intelligente-malattia_6aE3bZi285kZe9IoqU9PIX?refresh_ce<\/span><\/a><span style=\"font-size: 11pt; line-height: 16.866667px;\"><\/span><span style=\"font-size: 11pt; line-height: 115%; font-family: Symbol;\">\u00b7<span style=\"font-style: normal; font-variant-caps: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;; font-size-adjust: none; font-kerning: auto; font-variant-alternates: normal; font-variant-ligatures: normal; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-position: normal; font-feature-settings: normal; font-optical-sizing: auto; font-variation-settings: normal;\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><\/span><a href=\"https:\/\/www.tecnomedicina.it\/movi-presenta-lultima-innovazione-per-il-diabete\/\"><span style=\"font-size: 11pt; line-height: 16.866667px;\">https:\/\/www.tecnomedicina.it\/movi-presenta-lultima-innovazione-per-il-diabete\/<\/span><\/a><u><span style=\"font-size: 11pt; line-height: 16.866667px;\"><\/span><\/u><\/style><\/p>\n\n\n\n<p>The tour organized by\u00a0<strong>Movi SpA,<\/strong>\u00a0a leading distributor of\u00a0<strong>pioneering diagnostic and therapeutic solutions in the field of diabetes,<\/strong>\u00a0featured a series of events dedicated to healthcare professionals (with stops in Milan on 02\/26\/24, Bologna on 02\/27\/24, and Rome on 02\/28\/29\/24) for\u00a0<strong>the launch of an innovative integrated diabetes management system consisting of the Control-IQ technology pump and the Dexcom G7 sensor.<\/strong><\/p>\n\n\n\n<p>The round of presentation events focused mainly on illustrating\u00a0<strong>the system\u2019s unique features<\/strong>\u00a0and discussing its potential\u00a0<strong>positive impact on the daily lives of people undergoing insulin treatment<\/strong>. The presence of multiple legs in different cities across the country made it possible to engage a broader audience and at the same time to establish a network at the local level, which is useful for the\u00a0<strong>exchange of knowledge, experience, and specific issues that meet the needs of professionals dealing with diabetes.<\/strong><\/p>\n\n\n\n<p>The launch of this new technology on the Italian market is an extremely important event, because the\u00a0<strong>Tandem t:slim X2 pump with Control-IQ technology was the first AHCL (Advanced Hybrid Closed Loop) system to integrate with Dexcom G7, the \u201cBest in Class\u201d sensor on the market.<\/strong><\/p>\n\n\n\n<p>This state-of-the-art medical device,\u00a0<strong>launched by the Italian company Movi SpA<\/strong>, consists of a pump (<strong>Tandem t:slim X2 with Control-IQ technology<\/strong>), associated with a continuous blood glucose monitoring sensor (<strong>Dexcom G7<\/strong>) and a\u00a0<strong>predictive control algorithm<\/strong>\u00a0that\u00a0<strong>automates and customizes insulin delivery based on data from the sensor<\/strong>, responding to the specific needs of each person. This approach provides greater flexibility, autonomy, and quality of life for the user.<\/p>\n\n\n\n<p>Starting with careful listening and a detailed needs analysis,\u00a0<strong>the system was developed to truly meet the real needs of both physician and patient.<\/strong>\u00a0Among the main benefits of this new technology are\u00a0<strong>greater simplicity in diabetes management, increased reliability of the device, improved quality of life, increased safety in the delivery of glycemic data, and overall optimization of glycemic compensation.<\/strong><\/p>\n\n\n\n<p>With this\u00a0<strong>innovative device<\/strong>, people with diabetes will be able to achieve\u00a0<strong>a significant improvement in their quality of life,<\/strong>\u00a0as well as\u00a0<strong>greater simplicity of therapy management by the clinician<\/strong>.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>Press review:\u00a0<br><a href=\"https:\/\/www.adnkronos.com\/Archivio\/salute\/diabete-nuova-tecnologia-user-centered-per-gestione-intelligente-malattia_6aE3bZi285kZe9IoqU9PIX?refresh_ce\">https:\/\/www.adnkronos.com\/Archivio\/salute\/diabete-nuova-tecnologia-user-centered-per-gestione-intelligente-malattia_6aE3bZi285kZe9IoqU9PIX?refresh_ce<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.tecnomedicina.it\/movi-presenta-lultima-innovazione-per-il-diabete\/\">https:\/\/www.tecnomedicina.it\/movi-presenta-lultima-innovazione-per-il-diabete\/<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The tour organized by\u00a0Movi SpA,\u00a0a leading distributor of\u00a0pioneering diagnostic and therapeutic solutions in the field of diabetes,\u00a0featured a series of events dedicated to healthcare professionals (with stops in Milan on 02\/26\/24, Bologna on 02\/27\/24, and Rome on 02\/28\/29\/24) for\u00a0the launch of an innovative integrated diabetes management system consisting of the Control-IQ technology pump and the &hellip; <a href=\"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/\">Continued<\/a><\/p>\n","protected":false},"author":1,"featured_media":192,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-610","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-categorizzato"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Control-IQ &amp; Dexcom G7: The Latest Innovation For Diabetes - Movi diabete<\/title>\n<meta name=\"description\" content=\"Il lancio dell&#039;innovativo sistema integrato per la gestione del diabete costituito dal microinfusore con tecnologia Control-IQ &amp; Dexcom G7.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Control-IQ &amp; Dexcom G7 - Movi diabete\" \/>\n<meta property=\"og:description\" content=\"Il lancio dell&#039;innovativo sistema integrato per la gestione del diabete costituito dal microinfusore con tecnologia Control-IQ &amp; Dexcom G7.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/\" \/>\n<meta property=\"og:site_name\" content=\"Movi diabete\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-29T16:22:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-18T11:37:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/diabete.movigroup.com\/wp-content\/uploads\/2024\/04\/Articolo_02.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"pier\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"pier\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/\",\"url\":\"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/\",\"name\":\"Control-IQ &amp; Dexcom G7: The Latest Innovation For Diabetes - Movi diabete\",\"isPartOf\":{\"@id\":\"https:\/\/diabete.movigroup.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/diabete.movigroup.com\/wp-content\/uploads\/2024\/11\/contatol-iq-dexcom.jpg\",\"datePublished\":\"2024-02-29T16:22:00+00:00\",\"dateModified\":\"2025-03-18T11:37:53+00:00\",\"author\":{\"@id\":\"https:\/\/diabete.movigroup.com\/en\/#\/schema\/person\/9f1ac9d6cd185aa46a0c60d893efc741\"},\"description\":\"Il lancio dell'innovativo sistema integrato per la gestione del diabete costituito dal microinfusore con tecnologia Control-IQ & Dexcom G7.\",\"breadcrumb\":{\"@id\":\"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/#primaryimage\",\"url\":\"https:\/\/diabete.movigroup.com\/wp-content\/uploads\/2024\/11\/contatol-iq-dexcom.jpg\",\"contentUrl\":\"https:\/\/diabete.movigroup.com\/wp-content\/uploads\/2024\/11\/contatol-iq-dexcom.jpg\",\"width\":934,\"height\":343},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/diabete.movigroup.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Control-IQ &amp; Dexcom G7: The Latest Innovation For Diabetes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/diabete.movigroup.com\/en\/#website\",\"url\":\"https:\/\/diabete.movigroup.com\/en\/\",\"name\":\"Movi diabete\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/diabete.movigroup.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/diabete.movigroup.com\/en\/#\/schema\/person\/9f1ac9d6cd185aa46a0c60d893efc741\",\"name\":\"pier\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/diabete.movigroup.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/18b89cda0fe127cda327fb4dcbd5dc857a7617a4f91e3317d857f4f66f10a91c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/18b89cda0fe127cda327fb4dcbd5dc857a7617a4f91e3317d857f4f66f10a91c?s=96&d=mm&r=g\",\"caption\":\"pier\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Control-IQ &amp; Dexcom G7: The Latest Innovation For Diabetes - Movi diabete","description":"Il lancio dell'innovativo sistema integrato per la gestione del diabete costituito dal microinfusore con tecnologia Control-IQ & Dexcom G7.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/","og_locale":"en_US","og_type":"article","og_title":"Control-IQ & Dexcom G7 - Movi diabete","og_description":"Il lancio dell'innovativo sistema integrato per la gestione del diabete costituito dal microinfusore con tecnologia Control-IQ & Dexcom G7.","og_url":"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/","og_site_name":"Movi diabete","article_published_time":"2024-02-29T16:22:00+00:00","article_modified_time":"2025-03-18T11:37:53+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/diabete.movigroup.com\/wp-content\/uploads\/2024\/04\/Articolo_02.png","type":"image\/png"}],"author":"pier","twitter_card":"summary_large_image","twitter_misc":{"Written by":"pier","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/","url":"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/","name":"Control-IQ &amp; Dexcom G7: The Latest Innovation For Diabetes - Movi diabete","isPartOf":{"@id":"https:\/\/diabete.movigroup.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/#primaryimage"},"image":{"@id":"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/#primaryimage"},"thumbnailUrl":"https:\/\/diabete.movigroup.com\/wp-content\/uploads\/2024\/11\/contatol-iq-dexcom.jpg","datePublished":"2024-02-29T16:22:00+00:00","dateModified":"2025-03-18T11:37:53+00:00","author":{"@id":"https:\/\/diabete.movigroup.com\/en\/#\/schema\/person\/9f1ac9d6cd185aa46a0c60d893efc741"},"description":"Il lancio dell'innovativo sistema integrato per la gestione del diabete costituito dal microinfusore con tecnologia Control-IQ & Dexcom G7.","breadcrumb":{"@id":"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/#primaryimage","url":"https:\/\/diabete.movigroup.com\/wp-content\/uploads\/2024\/11\/contatol-iq-dexcom.jpg","contentUrl":"https:\/\/diabete.movigroup.com\/wp-content\/uploads\/2024\/11\/contatol-iq-dexcom.jpg","width":934,"height":343},{"@type":"BreadcrumbList","@id":"https:\/\/diabete.movigroup.com\/en\/control-iq-dexcom-g7-lultima-innovazione-per-il-diabete\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/diabete.movigroup.com\/en\/"},{"@type":"ListItem","position":2,"name":"Control-IQ &amp; Dexcom G7: The Latest Innovation For Diabetes"}]},{"@type":"WebSite","@id":"https:\/\/diabete.movigroup.com\/en\/#website","url":"https:\/\/diabete.movigroup.com\/en\/","name":"Movi diabete","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/diabete.movigroup.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/diabete.movigroup.com\/en\/#\/schema\/person\/9f1ac9d6cd185aa46a0c60d893efc741","name":"pier","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/diabete.movigroup.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/18b89cda0fe127cda327fb4dcbd5dc857a7617a4f91e3317d857f4f66f10a91c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/18b89cda0fe127cda327fb4dcbd5dc857a7617a4f91e3317d857f4f66f10a91c?s=96&d=mm&r=g","caption":"pier"}}]}},"_links":{"self":[{"href":"https:\/\/diabete.movigroup.com\/en\/wp-json\/wp\/v2\/posts\/610","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/diabete.movigroup.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/diabete.movigroup.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/diabete.movigroup.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/diabete.movigroup.com\/en\/wp-json\/wp\/v2\/comments?post=610"}],"version-history":[{"count":0,"href":"https:\/\/diabete.movigroup.com\/en\/wp-json\/wp\/v2\/posts\/610\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/diabete.movigroup.com\/en\/wp-json\/wp\/v2\/media\/192"}],"wp:attachment":[{"href":"https:\/\/diabete.movigroup.com\/en\/wp-json\/wp\/v2\/media?parent=610"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/diabete.movigroup.com\/en\/wp-json\/wp\/v2\/categories?post=610"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/diabete.movigroup.com\/en\/wp-json\/wp\/v2\/tags?post=610"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}